# Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer

**Authors:** Xiong Liu, Renming Yuan, Jie Peng, Ailei Xu, Xiaoxia Nie, Ruiti Tang, Guangqiang Li

PMC · DOI: 10.1038/s41598-024-55384-z · Scientific Reports · 2024-03-13

## Full-text entities

- **Genes:** PRELID3B (PRELI domain containing 3B) [NCBI Gene 51012] {aka C20orf45, SLMO2, UPS2, dJ543J19.5}
- **Diseases:** pan-cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10937915/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10937915/full.md

---
Source: https://tomesphere.com/paper/PMC10937915